Journal Information
Issue
Vol. 60. Issue S2.
Lung cancer: New perspectives
Pages S1-S88 (October 2024)
CO1
Arch Bronconeumol. 2024;60 Supl 2:CO1
Editorial
Challenges in the Management of Lung Cancer in ILD
Argyris Tzouvelekis, Panagiota Tsiri, Fotios Sampsonas
Arch Bronconeumol. 2024;60 Supl 2:S1-S3
Original articles
When to Consider Invasive Lymph Node Staging in Non–Small-Cell Lung Cancer? A Novel Scoring System Utilising Metabolic Parameters in 18F-FDG PET/CT
Figen Öztürk Ergür, Ayperi Öztürk, Özlem Özdağ, Ebru Tatcı, Özlem Özmen, Aydın Yılmaz
Arch Bronconeumol. 2024;60 Supl 2:S4-S12
Sex-specific Difference for Small Cell Lung Cancer from Immunotherapy Advancement
You Mo, Yiwei Qin, Jian Shangguan, Duncan Wei, Meng Wu, Dawei Chen, Jinming Yu
Arch Bronconeumol. 2024;60 Supl 2:S13-S21
Highlights

  • Provided the first evidence of a significant difference in immunotherapy advance among sex for SCLC based population mortality. Patient with SCLC in women benefit significantly.

Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Radiolung Integrative Predictive Model
Sonia Baeza, Debora Gil, Carles Sanchez, Guillermo Torres, João Carmezim, Cristian Tebé, Ignasi Guasch, Isabel Nogueira, ... Antoni Rosell
Arch Bronconeumol. 2024;60 Supl 2:S22-S30
Time Dependence Between Tobacco Consumption and Lung Cancer Mortality in Spain
Carla Guerra-Tort, Esther López-Vizcaíno, María Isolina Santiago-Pérez, Julia Rey-Brandariz, Cristina Candal-Pedreira, Alberto Ruano-Ravina, Mónica Pérez-Ríos
Arch Bronconeumol. 2024;60 Supl 2:S31-S37
Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry
Cristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, Manuel Cobo, Alexandra Cantero, Delvys Rodríguez-Abreu, Anna Estival, Enric Carcereny, ... Mariano Provencio
Arch Bronconeumol. 2024;60 Supl 2:S38-S45
Review articles
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, Nitish Kumar, Zuber Khan, Sourav Mohanto, Dinesh Kumar Chellappan, Arshad Farid, Farzad Taghizadeh-Hesary
Arch Bronconeumol. 2024;60 Supl 2:S46-S58
NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg
Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, Jyothi Venkat Sainath, Durgadevi Veeraiyan, Akhileshwar Namani
Arch Bronconeumol. 2024;60 Supl 2:S59-S66
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
Daniel Orive, Mirari Echepare, Franco Bernasconi-Bisio, Miguel Fernández Sanmamed, Antonio Pineda-Lucena, Carlos de la Calle-Arroyo, Frank Detterbeck, Rayjean J. Hung, ... Karmele Valencia
Arch Bronconeumol. 2024;60 Supl 2:S67-S76
Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer
Mei Xie, Xuwen Lin, Xinyu Bao, Yiran Liang, Hui Deng, Jialin Song, Xidong Ma, Xin Zhang, ... Xinying Xue
Arch Bronconeumol. 2024;60 Supl 2:S77-S85
Discussion letters
Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Correspondence
Hinpetch Daungsupawong, Viroj Wiwanitkit
Arch Bronconeumol. 2024;60 Supl 2:S86
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?